Regulatory PathRegulatory requirements compared

Active substance

Nitrofurazone

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
BECTAZON 0.2% OINTMENT0.2 %Ointment · Topical1 TubeSAR 4.65NCE · PrescriptionARAB CENTER FOR PHARMACEUTICALS & CHEMICAL IND. CO.Withdrawn by regulatory authority · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
FURACIN0.2%ointment · topicalSHIREDiscontinued4 Oct 1945
NITROFURAZONE0.2%ointment · topicalLANNETTDiscontinued5 Jun 1975
FURACIN0.2%powder · topicalSHIREDiscontinued17 Oct 1975
NITROFURAZONE0.2%ointment · topicalAMBIXDiscontinued26 Apr 1978
NITROFURAZONE0.2%ointment · topicalSUN PHARMA CANADADiscontinued15 Aug 1978
NITROFURAZONE0.2%ointment · topicalWENDTDiscontinued11 May 1981
NITROFURAZONE0.2%solution · topicalWENDTDiscontinued22 Jul 1981
FURACIN0.2%cream · topicalSHIREDiscontinued
NITROFURAZONE0.2%ointment · topicalPERRIGO NEW YORKDiscontinued
NITROFURAZONE0.2%solution · topicalPERRIGO NEW YORKDiscontinued
ACTIN-N0.2%dressing · topicalSHERWOOD MEDCLDiscontinued

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.